TCTR20180111001尚未招募未知
Efficacy and safety of generic voriconazole for treatment of invasive fungal infections
Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 95 人开始时间: 2018年1月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 95
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •Patients 18 years of age or older who diagnosed invasive fungal infection
排除标准
- •History of voriconazole allergy
- •Received medication that have significant interactions with voriconazole
研究者
相似试验
已完成
不适用
Efficacy and safety of fosravuconazole for the treatment of onychomycosis: A multicenter, retrospective studyOnychomycosisJPRN-UMIN000045924Sato Pharmaceutical Co.,Ltd350
已完成
不适用
Study of the effectiveness of voriconazole in the treatment of Aspergillus fumigatus associated asthmaAsthmaRespiratoryISRCTN42366088niversity Hospitals of Leicester NHS Trust (UK)70
进行中（未招募）
1 期
Study of the effectiveness of Voriconazole in the treatment of Aspergillus fumigatus associated asthma - Effectiveness of Voriconazole in Aspergillus associated asthmaAsthma with sensitization to aspergillus and isolation in sputum.EUCTR2009-011452-21-GBniversity Hospitals of Leicester NHS trust
招募中
4 期
comparative evaluation of oral voriconazole and oral ketoconazole in severe fungal keratitisCTRI/2016/07/007103DR R P Centre AIIMS New Delhi40
已完成
3 期
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsFungemiaMycosesCandidiasisAspergillosisNCT00001810National Cancer Institute (NCI)300